Correction|Volume 12, Issue 7|pp 6488—6489

Correction for: Lycorine induces autophagy-associated apoptosis by targeting MEK2 and enhances vemurafenib activity in colorectal cancer

Man Hu¹, Zhaomin Yu¹, Peiyuan Mei², Jinxiao Li¹, Dan Luo³, Haiming Zhang⁴, Minfeng Zhou⁵, Fengxia Liang⁵, Rui Chen¹

¹Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
²Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
³Department of Respiratory Medicine, Wuhan First Hospital, Wuhan, China
⁴Department of Oncology, Integrated Traditional Chinese and Western Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁵Department of Acupuncture, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, China

Received: March 23, 2020Accepted: March 26, 2020Published: April 2, 2020

Copyright © 2020 Hu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been corrected: The authors requested the replacement of panel B in Figure 4. The mistake is in posting of the same GAPDH bands in both Figure 4A and Figure 4B due to carelessness

This correction does not change the content of the publication and do not affect the conclusion of this research.

The corrected Figure 4 is provided below.

Figure 4.

Lycorine enhances the anti-cancer effects of vemurafenib. (B) Mitogen-activated protein kinase kinase 2 (MEK2) was depleted in MEK2-overexpressing HCT116 cells by exposure to lycorine, and western blotting was used to investigate the levels of autophagy and apoptosis. GAPDH was used as a loading control.